It has been found that LSD-1 is involved in several cancers, including prostate, bladder, lung cancers, neuroblastoma, sarcomas and hepatocarcinomas.11 High expression levels of LSD-1 in cancer cells suggested LSD-1 as a druggable target for cancer treatment. This evidence concerns the gene KDM1A and neuroblastoma.